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The Effect of Hypothermic and Cryogenic Preservation
on Engineered Neural Tissue
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Lara Stevanato, BSc, PhD,2 and James B. Phillips, BSc, PhD1
This study explored different approaches to preserve engineered neural tissue (EngNT), a stabilized, cellular collagen
hydrogel containing columns of aligned Schwann cells for nervous system repair. The ability to preserve EngNT without
disrupting cellular and extracellular components and structures is important for clinical translation and commerciali-
zation. Stabilized cellular gels and EngNT constructs were preserved under various conditions and cell survival assessed
using live/dead microscopy and metabolic assay. Optimal survival was recorded in hypothermic (4C) conditions for 2–
3 days using Hibernate-A media and, for longer-term cryogenic storage (liquid nitrogen), using a mixture of 60%
Dulbecco’s modified Eagle’s medium, 30% fetal bovine serum, and 10% dimethyl sulfoxide. Functionality and structure
of preserved EngNT were assessed in coculture with dorsal root ganglion neurons, which indicated that alignment of
Schwann cells and the ability of EngNT to support and guide neuronal regeneration were not disrupted. The identifi-
cation of conditions that preserve EngNT will inform development of storage and transport methodologies to support
clinical and commercial translation of this technology and other therapies based on cellular hydrogels.
Keywords: collagen, Schwann cell, preservation, hypothermic, cryogenic, nerve guide, nerve regeneration,
nerve tissue engineering, hydrogel
Introduction
Engineered neural tissue (EngNT) is an alignedcellular biomaterial that can be formed from a combi-
nation of Schwann cell self-alignment and stabilization in
collagen gels.1 Our previous work showed EngNT to be a
potential alternative to the current clinical gold standard au-
tograft for treating peripheral nerve injuries, with the ability
to support neuronal regeneration and the capacity to be con-
structed using therapeutic cells.1–4 To support commerciali-
zation and clinical translation of EngNT, it would be beneficial
to be able to store the living cellular constructs in such a
manner that preserves their cell viability and architecture. This
would allow flexibility in the timing between manufacture and
usage, enabling manufacturing to be conducted in a specialist
facility with subsequent distribution to clinical centers. Fur-
thermore, the ability to store an allogeneic off-the-shelf for-
mulation of EngNT could allow clinics to maintain stock
locally.
The two main methods used to preserve cells and tissues
are hypothermic and cryogenic storage. Successful hypo-
thermic preservation of tissue, which involves refrigeration
rather than freezing of samples, has been shown using Collins
solution and University of Wisconsin solution (marketed as
ViaSpan).5–7 Effective hypothermic preservation of neuronal
cells has been shown using Hibernate-A, Hibernate-E, and
HypoThermosol FRS (HTS-FRS).8–10 Brewer et al. have
shown that Hibernate-E (Hibernate-E has a higher osmolality
than Hibernate-A; 240 and 280 mOsm/kg H2O, respectively)
can successfully preserve brain tissue,11 although there is no
literature exploring the ability of these solutions to preserve
nerve grafts or EngNT. The most common way to preserve
cells/tissue cryogenically is with the use of the cryoprotectant
dimethyl sulfoxide (DMSO).12,13 Kawamoto et al. demon-
strated that freezing neurons with 5–10% DMSO was optimal
for survival14; <5% DMSO did not provide enough protection
to cells from freezing effects and above 10% DMSO was
toxic to cells. Similar to cryopreserving cell suspensions, 10%
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DMSO has also been found to be optimal when cryopreserving
primary nerve tissue.13 For example, Das et al.15 showed that
cryopreserving rat neocortical and brainstem tissues using
2–4% DMSO was inferior to using 10% when subsequently
transplanted into the cerebellum of neonatal host rats.
Hashimoto et al.16 showed that cryopreserving bovine brain
tissue with 4% or 8% DMSO was inferior to 10%. Concentra-
tions of DMSO higher than 10–15% have also been found to
reduce cell survival when cryopreserving rat,17 bovine,16 and
human tissues.18 Fansa et al. reported harvesting nerve grafts
from rats and storing them cryogenically using Dulbecco’s
modified Eagle’s medium (DMEM) and 10% DMSO.19 After
24 h, nerve grafts were transplanted back into the same animal
and left for 6 weeks. Some nerve graft samples were histolog-
ically analyzed without reimplantation to determine whether
freezing altered the structural features of the grafts. Although
structural features of the grafts stored with a cryoprotectant
were not altered, morphometric results after 6 weeks showed
that cryopreserved grafts were inferior at supporting regener-
ation as fewer axons and less myelination were found compared
with samples that were not exposed to any cryogenic condi-
tions. The authors speculate that impaired regeneration could be
attributed to delayed Wallerian degeneration and slower re-
vascularization. Furthermore, a reduced survival of resident
Schwann cells in the cryogenically stored graft may have
impaired regeneration.19
The aim of this study was to investigate the effects of a
range of hypothermic and cryogenic storage approaches on
the viability, structure, and function of EngNT seeded with
rat Schwann cells. The key outcome measures under con-
sideration were the viability of the cells within the constructs
and preservation of the architecture of EngNT. Storage media
and protocols were selected and compared using simplified
tissue constructs to investigate cell viability after different
storage periods, then the ability of promising candidate con-
ditions to preserve EngNT structure and function was assessed.
Materials and Methods
Production of cellular collagen gels
Collagen hydrogels containing Schwann cells were manu-
factured according to previously established protocols and
stabilized using plastic compression.20 Schwann cells (SCL
4.1/F7; Health Protection Agency, United Kingdom) were
maintained in DMEM (Gibco) supplemented with penicillin
and streptomycin (100 U/mL and 100 mg/mL, respectively;
Sigma, United Kingdom) and 10% v/v fetal bovine serum
(FBS; Gibco) in standard cell culture flasks in a 37C incu-
bator with 5% carbon dioxide (CO2) and passaged with
trypsin/EDTA (Life Technologies, United Kingdom) when
required. Acid-solubilized type I bovine collagen (3 mg/mL;
Koken, Japan) was diluted with 26.8% v/v 1 mM hydrochloric
acid to a concentration of 2 mg/mL. This solution was then
mixed with 10% v/v 10·minimum essential medium (Sigma)
and neutralized (*0.5% v/v neutralizing solution; Lonza
Bioscience, United Kingdom) before addition of 10% v/v
culture media containing Schwann cells. To produce simple
unaligned gels for initial experiments, 1 mL of cellular col-
lagen solution (2· 106 cells/mL) was cast per well of a 24-well
plate. To manufacture aligned gels for EngNT production,
400mL of cellular collagen solution (4· 106 cells/mL) was
added to tethering molds that allowed self-alignment.21 Un-
aligned cellular collagen gels were used for the initial exper-
iments because a higher throughput could be achieved and a
greater number of identical pieces could be obtained from
simple unaligned gels compared with EngNT. Gels were in-
cubated at 37C for 15 min to set. Unaligned collagen gels
were stabilized for 15 min using the RAFT absorber (Lonza
Bioscience). Tethered gels were immersed in culture media
and incubated for 24 h to allow cellular self-alignment,1 then
media removed before stabilization using RAFT to generate
EngNT.
Preservation conditions
Unaligned cellular collagen gels were used in initial ex-
periments to determine the appropriate preservation condi-
tions for cell survival. Each circular gel was cut radially into
six equal sectors that were transferred to six different preser-
vation conditions for 2 days. Three pieces were preserved in
hypothermic conditions (refrigerated at 4C): (1) Hibernate-A
(Gibco), (2) DMEM 10% FBS, and (3) HTS-FRS (BioLife
Solutions). Three pieces were preserved in cryogenic condi-
tions through controlled rate cooling using (4) 80% DMEM
+10% FBS +10% DMSO, (5) 60% DMEM +30% FBS +10%
DMSO, and (6) 90% HTS-FRS +10% DMSO (Mr. Frosty
freezing container for 1 day in a -80C freezer, followed by
2 days in liquid nitrogen). Fresh gels not exposed to preser-
vation conditions were used as controls. These were analyzed
immediately by live/dead assay using Syto-9 (5mM; Life
Technologies) and propidium iodide (20mg/mL; Sigma-
Aldrich, United Kingdom), respectively, diluted in cell culture
media, and incubated at room temperature for 1 min before
viewing. Preserved samples were rapidly warmed in a 37C
water bath after the preservation period and then live/dead
assay performed as described above. Further experiments were
conducted on unaligned gels and EngNT using the following
preservation conditions: Hibernate-A, HTS-FRS, 60% DMEM
+30% FBS +10% DMSO, and 90% HTS-FRS +10% DMSO
(unaligned gels only) using the methods described above for
durations of 2, (EngNT only), 7, and 14 days at 4C or in liquid
nitrogen. Samples stored in liquid nitrogen were first cooled to
-80C (Mr. Frosty freezing container for 1 day). For testing
aligned cellular gels, EngNT constructs were cut into quarters,
unless otherwise stated.
Metabolic assessment of EngNT
CellTiter-Glo (Promega, United Kingdom) was used to
quantify the presence of viable Schwann cells in EngNT before
and after preservation in Hibernate-A for 3 days. Each EngNT
sample was cut transversely into two equal pieces, each con-
taining 0.8· 106 cells, one of which was tested immediately
(baseline control) and the other subjected to preservation for
3 days at 4C in Hibernate-A or DMEM 10% FBS, then re-
turned to standard culture conditions (37C 5% CO2 in DMEM
10% FBS) for 1 or 3 days, then tested. Equivalent control
samples were maintained under standard culture conditions for
the entire duration (4 or 6 days). One hundred microliters of
CellTiter-Glo and 100mL of DMEM 10% FBS along with each
sample were added to each well of an opaque 96-well plate and
placed on a shaker at 100 rpm. After 10 min, the plate was
incubated statically for a further 20 min at room temperature
(21C). Luminescence (*528 nm) of each sample was then
read using an FLX800 (BioTek) plate reader. Luminescence
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from blank control wells was subtracted from samples
containing gels.
Coculture of preserved EngNT with neurons
Coculture experiments were used to investigate whether
EngNT preserved in Hibernate-A or 60% DMEM, 30%
FBS, and 10% DMSO after 3 days would guide and support
dorsal root ganglion (DRG) neurons compared with EngNT
left in normal culture conditions for 3 days (no preservation).
All experimental procedures involving animals were con-
ducted in accordance with the UK Animals (Scientific Proce-
dures) Act (1986) and approved by the relevant UCL ethics
review board. Dissociated DRG neurons were prepared from a
single adult (200–300 g) Wistar rat. DRGs were incubated in
collagenase IV (0.125%; Sigma) for 90 min at 37C, then
dissociated by trituration and washed twice with 20 mL of
culture medium before being incubated for 24 h with cytosine
arabinoside (0.01 mM) to deplete glia. The resulting cultures
were enriched with neurons,1 which were washed twice with
20 mL of culture medium through centrifugation at 400 g for
5 min and resuspended into a final volume of 600mL. After
thawing cryogenically preserved samples in a 37C water bath
and then washing preserved EngNT samples with 37C
DMEM 10% FBS, neurons were seeded through pipetting
50mL onto each surface of quartered EngNT sheets. Neurons
were left in a 37C humidified incubator with 5% CO2 for 1.5 h
to allow attachment, after which EngNT sheets were immersed
in 1 mL of DMEM 10% FBS and incubated for 3 days. Sam-
ples were then washed in phosphate-buffered saline and fixed
in 4% paraformaldehyde for at least 24 h at 4C before im-
munofluorescence staining was carried out as described pre-
viously for collagen gels22,23 to detect bIII-tubulin-positive
neurons (1:400, anti-mouse; Sigma-Aldrich) and S100-
positive Schwann cells (1:400, anti-rabbit; Dako, United
Kingdom). Secondary antibodies (DyLight 488 goat anti-
rabbit IgG and DyLight 549 horse anti-mouse IgG; Vector
Laboratories, United Kingdom) were then used (1:200) for
90 min at ambient temperature (21C) to detect the primary
antibody.
Scanning electron microscopy
Scanning electron microscopy (SEM) was used to assess
whether EngNT preserved in Hibernate-A or 60% DMEM,
30% FBS, and 10% DMSO for 3 days affected collagen
alignment compared with EngNT maintained in normal
culture conditions for 3 days (no preservation). Samples
were fixed in 3% glutaraldehyde for at least 24 h at 4C, then
dehydrated through an increasing graded series of ethanol.
Finally, samples were fully immersed in hexamethyldisila-
zane for 2 min, which was then removed, and samples were
left to dry. Samples were mounted onto aluminum SEM
stubs using double-sided carbon sticky tabs (Agar Scientific,
United Kingdom), sputter coated with gold palladium, and
imaged using a Philips XL30 FEGSEM at 5 kV.
Microscopy and image analysis
Samples were placed onto microscope slides and imaged
immediately after live/dead staining using a 20 · objective
on a Zeiss Axioskop fluorescence microscope. Five equiv-
alent predetermined fields were assessed on each piece of
unaligned gel to find the mean cell death percentage. Seven
predetermined fields were assessed for each quartered EngNT
sample.
Schwann cell and neurite alignment and growth were
assessed using confocal microscopy (LSM710; Zeiss, Ger-
many) by tile scanning the entire quarter of each EngNT
sheet. Images were captured using a 20 · lens, using z-stacks
of 18mm for neurites and 25 mm for Schwann cells with a
step size of 2mm. Alignment analysis was conducted using
Volocity software (Perkin Elmer, Waltham, MA) running
automated 3D image analysis protocols to measure the angle
of Schwann cell and neurite alignment in each field.21
Statistical analysis was carried out using analysis of vari-
ance with Tukey’s or Dunnett’s post-tests (GraphPad Prism).
Results
Survival of Schwann cells in preserved collagen gels
An initial panel of preservation conditions was tested to
determine what medium formulation and method (hypo-
thermic or cryogenic) minimized cell death optimally after
2 days within unaligned collagen gels compared with baseline
control gels (Fig. 1A). Ninety percent HTS FRS 10% DMSO
was included because of its similar formulation to the com-
mercial product Cryostor. Preliminary data indicated that
increasing the concentration of FBS in the formulation of
cryogenic media was not beneficial to cell survival, with 25%
DMEM, 65% FBS, and 10% DMSO and 90% FBS and 10%
DMSO resulting in 38.8% and 37.5% cell death, respec-
tively, after 2 days. Samples preserved hypothermically with
Hibernate-A and HTS-FRS resulted in lower cell death than
all other conditions. Hibernate-A samples were not signifi-
cantly different in terms of cell death compared with control
samples, but a significant difference was found using HTS-
FRS. Of the cryogenically preserved samples, the condition
60% DMEM, 30% FBS, and 10% DMSO resulted in lower
cell death than other cryogenic conditions, but was signif-
icantly different from the control samples. Following this
initial study, the two hypothermic and cryogenic conditions
associated with the lowest levels of cell death in each case
were used in studies lasting 7 and 14 days (Fig. 1B). Cell
death increased with storage time regardless of the preser-
vation condition used. At day 7, hypothermic preservation
using Hibernate-A only raised cell death compared with ini-
tial control samples by 7.2% to 26.2%, whereas all other
conditions tested showed an increase in cell death to 40–50%.
By day 14, cell death in Hibernate-A samples had increased
to 45% and the other hypothermic condition (HTS-FRS) had
increased to 72% cell death.
Survival of Schwann cells in preserved EngNT
Following initial experiments using simple, unaligned
collagen gels, the survival of Schwann cells in EngNT
constructs was measured after hypothermic preservation in
Hibernate-A or cryogenic preservation in 60% DMEM, 30%
FBS, and 10% DMSO (Fig. 2). Similarly to the unaligned gels,
cell death increased with time in samples preserved hy-
pothermically, whereas cell death in cryogenic preservation
conditions was 47% at 2 days, remained similar at 7 days, and
only increased by *10% by day 14.
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Due to the substantial increase in cell death between days 2
and 7 using hypothermic storage in Hibernate-A, additional
time points were investigated for this condition to explore the
time course in more detail. Samples tested at days 2 and 3
were not significantly different in cell death compared with
control samples, then from day 4 onward, a significant in-
crease in cell death was detected with increasing time.
Metabolic activity of Schwann cells
within EngNT postpreservation
To test the viability of cells within EngNT following
preservation, metabolic activity was determined after pre-
served samples were returned to standard culture conditions
and maintained for 1 and 3 days (Fig. 3). Preserved samples
and those that had been maintained in culture (DMEM 10%
FBS) for the duration had significantly decreased ATP levels
compared with fresh samples analyzed immediately after
construction. The samples preserved in Hibernate-A showed
a significantly higher metabolic activity than equivalent
samples maintained in culture at the 4-day time point, but this
difference between conditions was not present after 6 days.
Schwann cell and collagen alignment in EngNT
and guidance of neurite growth following preservation
Coculture experiments using primary rat DRG neurons
were used to investigate whether EngNT preserved for
3 days in Hibernate-A (hypothermic) or 60% DMEM, 30%
FBS, and 10% DMSO (cryogenic) would guide and support
DRG neurons compared with EngNT maintained under stan-
dard culture conditions (DMEM 10% FBS) for 3 days (no
preservation). Schwann cell alignment and neuronal growth
and guidance did not appear to be affected by the preservation,
and scanning electron micrographs indicated that collagen
alignment was also unaffected by the preservation (Fig. 4A).
Schwann cell alignment within preserved EngNT samples was
FIG. 1. Schwann cell death in unaligned gels following preservation. Unaligned gels were initially preserved in six different
conditions for 2 days and compared with baseline day 0 control gels (dotted line: 19.5%– 9%) through one-way ANOVA (A).
Dunnett’s post-tests revealed significant differences in cell death in preserved samples compared with controls (*p< 0.05,
***p< 0.001). The two hypothermic and cryogenic conditions associated with the lowest levels of cell death in each case were
then investigated further to include days 7 and 14 (B). Two-way ANOVA revealed a main effect between conditions, time, and
their interaction ( p< 0.001). Significant differences between conditions in terms of cell death at each time point were found
using Tukey’s post-tests (*p< 0.05, ***p< 0.001). Excluding Hibernate-A at day 7, all samples showed significantly greater
cell death compared with control (day 0) samples (dotted line, 19.6%– 6.8%, p< 0.001). Samples stored hypothermically
significantly increased in cell death by 14 days compared with corresponding conditions at day 7 (###p< 0.001). n= 6, data are
mean–SEM. ANOVA, analysis of variance; DMEM, Dulbecco’s modified Eagle’s medium; DMSO, dimethyl sulfoxide;
FBS, fetal bovine serum; HTS-FRS, HypoThermosol FRS; SEM, standard error of mean.
FIG. 2. Comparison of Schwann cell death (%) in EngNT
preserved using Hibernate-A (hypothermic condition) and
60% DMEM, 30% FBS, and 10% DMSO (cryogenic con-
dition). After testing for 2, 7, and 14 days, further analysis of
EngNT preserved using Hibernate-A was carried out to in-
clude days 3 and 4. Day 0 represents unpreserved control
samples. ANOVA with Dunnett’s post-tests revealed sig-
nificant increases in cell death compared with controls at
day 0 (***p < 0.001). n = 6, data are mean – SEM. EngNT,
engineered neural tissue; FBS, fetal bovine serum.
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not significantly different from control samples, with*50% of
cells showing a deviation of <30 from the long axis of EngNT
(Fig. 4B). A similar trend was seen in the alignment of neurites
with no significant difference between preserved samples,
where the orientation of 61% (Hibernate-A) and 55% (cryo-
genic) of neurites deviated by <30 from the long axis of
EngNT, compared with 50% in control samples (Fig. 4C).
Discussion
Our previous work showed EngNT to be a potential al-
ternative to the current gold standard autograft and better
than an empty tube for repairing critical length gaps in a rat
peripheral nerve transection model.1,2 To support clinical
translation of EngNT, an optimal method for storing cellular
constructs between manufacture and implantation that pre-
serves cell viability and functional architecture would be
beneficial.
Experiments using unaligned cellular constructs indicated
that hypothermic conditions were more appropriate for
short-term storage and cryogenic conditions enabled longer-
term storage, with a range of outcomes in terms of cell death
using different medium preparations. The most effective cryo-
genic medium formulation tested here was 60% DMEM, 30%
FBS, and 10% DMSO, which resulted in *25% initial cell
death compared with controls, but remained relatively stable
over time. This 25% initial cell death is consistent with other
studies investigating storage of tissue-engineered constructs. For
example, Elder et al.24 cryopreserved collagen-based blood
vessel constructs overnight using DMEM supplemented with
10% FBS and 1 mol/L DMSO and reported 25% increase in
cell death compared with control samples, and Costa et al.25
found decreased levels of DNA and metabolic activity from goat
bone marrow stem cells cryogenically preserved in 3D porous
scaffolds for 7 days using DMEM, FBS, and DMSO compared
with control samples.
The most effective medium formulation tested here in
terms of minimizing Schwann cell death during hypothermic
storage was Hibernate-A. Short-term preservation (2 days)
was better using hypothermic methods rather than cryogenic
methods, which is unsurprising since at subzero conditions,
ice formation in the extracellular medium creates an osmotic
gradient across cell membranes that results in water being
drawn out of the cells.13,26 As the samples are cooled further,
water continues to be drawn out of the cells, causing cell
shrinkage. This causes intracellular solutes to become con-
centrated that can be toxic to cells, resulting in cell death.13,26
Hibernate-A has been used to increase neuron survival dur-
ing tissue dissociation and to preserve rat embryonic brain
tissue,11,27,28 but has never been used to preserve cells in
EngNT before. In the present study, EngNT stored for up to
3 days under hypothermic conditions in Hibernate-A showed
minimal increase in Schwann cell death compared with
controls, whereas after storage for 4 days or longer, Schwann
cell death gradually increased with time. This provides im-
portant new information about the feasibility of using hypo-
thermic conditions to store and transport cellular biomaterials
in the days immediately following manufacture.
After identification of hypothermic and cryogenic ap-
proaches that enabled simplified unaligned cellular constructs
to survive, further studies were conducted to investigate
whether the structure and function of EngNT were disrupted
under the same conditions. After the preservation period,
samples were returned to standard culture for 1 and 3 days and
their metabolic activity was assessed. There was a decrease in
metabolic activity in EngNT after time in culture regardless of
whether preservation conditions or standard culture conditions
were used. Interestingly, at day 4, the EngNT that had been
stored hypothermically was more metabolically active than the
equivalent sample that had been maintained at 37C, indicating
that the baseline reduction in metabolic activity over time
in vitro was reduced in hypothermically stored samples. By
6 days, there was no difference between preserved and cultured
samples, which is consistent with the data obtained from the
cell death studies in EngNT that also showed hypothermic
preservation was most effective for up to 3 days. Kawamoto
et al.14 developed an optimized preservation medium for
storing fetal rat central nervous system tissue and reported a
significant reduction in cell survival after 8 days, which is
similar to the effect on cell survival following hypothermic
storage of EngNT shown here. This medium formulation had a
pH of 6.8–7.4 and included 30–70 mM K+, 10–30 mM Na+, 5–
50 mM PO2-, 20 mM lactic acid, 5 mM glucose, and <0.1 mM
Ca2+. This medium is similar to Hibernate-A used in this study,
but contains lower concentrations of sodium and calcium.
Brewer et al.11 indicated that neuron survival was higher using
Hibernate-E supplemented with B27 than the media described
in Ref.14 Kawamoto et al. suggested that cell death during
hypothermic storage over longer time periods could be due to
biophysical stresses such as ionic fluxes across cell
FIG. 3. Metabolic activity of EngNT with and without
preservation in Hibernate-A. After 3 days in Hibernate-A,
preserved samples were put back into culture conditions for
1 day (4 days total time) or 3 days (6 days total) and
compared with equivalent samples maintained in culture for
4 and 6 days. Two-way ANOVA revealed a main effect
between conditions ( p < 0.05), time ( p < 0.001), and their
interaction ( p < 0.05). Two-way ANOVA with Tukey’s
post-tests showed that control samples (analyzed immedi-
ately after construction) had significantly higher metabolic
activity than all other samples (dotted line, 186,000– 8000;
p < 0.001). The hypothermic condition at day 4 had signifi-
cantly higher metabolic activity than the other samples at
days 4 and 6 (**p < 0.01, ***p < 0.001). n = 4, data are
mean – SEM.
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membranes, pH changes due to build-up of acidic metabolites,
energy deprivation, exposure to toxic debris, and degradation
by proteolytic enzymes released by damaged cells.14 Sub-
sequent studies used this hibernation approach to preserve fetal
ventral mesencephalic tissue grafts successfully for a number
of days under hypothermic conditions.29,30 From these studies
and the results reported here, it is clear that EngNT, like natural
neural tissues, can be stored for a few days under hypothermic
conditions, but for longer-term storage, this will result in a
reduction in cell viability, so for those situations, cryopreser-
vation is the better option.
Alignment of Schwann cells and nanofibrillar collagen
matrix in EngNT and other artificial grafts contributes to
guidance of neuronal regeneration through a nerve injury
site.1,2,31–34 It was therefore important to investigate whe-
ther the anisotropic cellular and extracellular architecture in
EngNT constructs was maintained following preservation
in conditions that were sufficient to maintain cell viability.
FIG. 4. Collagen, Schwann cell, and neurite alignment in EngNT after cryogenic or hypothermic preservation. EngNT
samples were preserved hypothermically in Hibernate-A or cryogenically in 60% DMEM, 30% FBS, and 10% DMSO or
maintained in culture for 3 days, then cocultured with neurons for 3 days. Scanning electron micrographs show collagen
structure, and fluorescence micrographs (20· ) show aligned Schwann cells (green, S100) and aligned neurite growth (red,
bIII-tubulin) in control, hypothermic, or cryogenic EngNT samples (A). Confocal tile scan micrographs of each sample were
used to calculate Schwann cell (B) and neurite (C) alignment in relation to the long axis of EngNT (n= 4 for preservation
conditions and n= 3 for control, data are mean–SEM). Color images available online at www.liebertpub.com/tec
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Results from confocal image analysis of Schwann cell
alignment and alignment of cocultured neurons indicated
that both hypothermic and cryogenic preservation methods
using the optimal medium formulations and timing for cell
survival were not detrimental to EngNT structure, with neurite
alignment in vitro being equivalent to previous studies.1
Conclusion
Medium conditions for hypothermic and cryogenic stor-
age of EngNT were compared and formulations were iden-
tified that supported survival of resident Schwann cells in
each case. For short-term preservation of up to 3 days,
Hibernate-A at hypothermic storage temperature was optimal.
For longer-term preservation, cryogenic storage using a me-
dium formulation, including 30% FBS and 10% DMSO, was
optimal. In each case, Schwann cell alignment within EngNT
was not affected and the ability of the constructs to guide
neurite growth in coculture was not diminished. The results of
this study will contribute to the clinical and commercial
translation of EngNT and may also be of benefit to other
groups seeking to preserve cellular materials for nerve repair
or for other tissue engineering applications. Future work will
focus on optimization of preservation of EngNT using ther-
apeutically relevant cells under good manufacturing practice
guidelines, along with testing in vivo, to improve the scale-up
and clinical translation of this technology.
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